Blood vessel epicardial substance reduces LRP6 receptor and cytoplasmic β-catenin levels to modulate Wnt signaling and intestinal homeostasis.


Journal

Carcinogenesis
ISSN: 1460-2180
Titre abrégé: Carcinogenesis
Pays: England
ID NLM: 8008055

Informations de publication

Date de publication:
18 Sep 2019
Historique:
received: 12 10 2018
revised: 19 12 2018
accepted: 18 01 2019
medline: 29 1 2019
pubmed: 29 1 2019
entrez: 29 1 2019
Statut: ppublish

Résumé

Blood vessel epicardial substance (BVES, otherwise known as POPDC1) is an integral membrane protein known to regulate tight junction formation and epithelial-mesenchymal transition. BVES is underexpressed in a number of malignancies, including colorectal cancer. BVES loss leads to activation of the Wnt pathway, suggesting that decreased BVES expression functionally contributes to tumorigenesis. However, the mechanism by which BVES modulates Wnt signaling is unknown. Here, we confirm that BVES loss increases β-catenin protein levels, leads to Wnt pathway activation in a ligand-independent fashion and coordinates with Wnt ligand to further increase Wnt signaling. We show that BVES loss increases levels and activation of the Wnt co-receptor, LRP6, in cell lines, murine adenoma tumoroids and human-derived colonoids. We also demonstrate that BVES interacts with LRP6. Finally, murine tumor modeling using a Wnt-driven genetic model and a chemically induced model of colorectal carcinogenesis demonstrate that BVES loss increases tumor multiplicity and dysplasia. Together, these results implicate BVES as an inhibitor of Wnt signaling, provide one of the first examples of a tight junction-associated protein regulating Wnt receptor levels, and expand the number of putative molecular targets for therapeutic intervention in colorectal cancer.

Identifiants

pubmed: 30689807
pii: 5299709
doi: 10.1093/carcin/bgz007
pmc: PMC8067673
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1086-1098

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR000445
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK099204
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK058404
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NIDDK NIH HHS
ID : F30 DK111107
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007347
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA236733
Pays : United States
Organisme : NIDDK NIH HHS
ID : F32 DK108492
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA068485
Pays : United States
Organisme : BLRD VA
ID : I01 BX001426
Pays : United States

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Auteurs

Joshua J Thompson (JJ)

Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.

Sarah P Short (SP)

Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.

Bobak Parang (B)

Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.

Rachel E Brown (RE)

Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.

Chenxuan Li (C)

Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Victoria H Ng (VH)

Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN, USA.

Kenyi Saito-Diaz (K)

Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN, USA.

Yash A Choksi (YA)

Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.

Mary K Washington (MK)

Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, TN, USA.

Jesse Joshua Smith (JJ)

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Barbara Fingleton (B)

Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, USA.

Thomas Brand (T)

National Heart and Lung Institute, Imperial College London, London, UK.

Ethan Lee (E)

Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN, USA.

Robert J Coffey (RJ)

Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Veterans Affairs Tennessee Valley Health Care System, Nashville, TN, USA.

Christopher S Williams (CS)

Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Veterans Affairs Tennessee Valley Health Care System, Nashville, TN, USA.

Classifications MeSH